Clinical Trial

Tirzepatide in Participants with Impaired Liver Function

Study Description

A Study of Tirzepatide in Participants With Impaired Liver Function

The purpose of this study is to assess how fast tirzepatide gets into the blood stream and how long it takes the body to remove it in participants with impaired liver function compared to healthy participants. The study will last about two months and will include five visits to the study center.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Tirzepatide

Administered SC

Additional Information

Official Study Title

A Single Dose Pharmacokinetic Study of Tirzepatide in Subjects With Varying Degrees of Hepatic Impairment

Clinical Trial ID

NCT03940742

ParticipAid ID

bo2kYa